Literature DB >> 15358898

Managing safety and risk: the experiences of people with Parkinson's disease who use alternative and complementary therapies.

Jacqueline Low1.   

Abstract

In this article I focus on how individuals living with Parkinson's disease manage safety and risk in their participation in alternative and complementary health care. I take a qualitative approach in this research, using semi-structured interviews and grounded theory techniques as means of generating and analysing data. My analysis centres on how these informants construct certain therapies as risk free and therefore safe, and others as risky and thus, inherently unsafe. I discuss the knowledge bases these informants draw on in their evaluations and describe the social contexts in which these assessments take place. While there is a substantial literature on risk in general, as well as the risk society, there has been less interest in micro-level analysis of risk. This article therefore contributes to knowledge through its focus on management of safety and risk in individuals' health-seeking behaviour.

Entities:  

Mesh:

Year:  2004        PMID: 15358898     DOI: 10.1177/1363459304045698

Source DB:  PubMed          Journal:  Health (London)        ISSN: 1363-4593


  3 in total

1.  Beliefs About Use of Complementary Health Approaches for Parkinson's Disease.

Authors:  Ju Young Shin; Ryan T Pohlig; Barbara Habermann
Journal:  Holist Nurs Pract       Date:  2017 Sep/Oct       Impact factor: 1.000

2.  Evaluating complex health interventions: a critical analysis of the 'outcomes' concept.

Authors:  Charlotte Paterson; Charlotte Baarts; Laila Launsø; Marja J Verhoef
Journal:  BMC Complement Altern Med       Date:  2009-06-18       Impact factor: 3.659

3.  Use of bodily sensations as a risk assessment tool: exploring people with Multiple Sclerosis' views on risks of negative interactions between herbal medicine and conventional drug therapies.

Authors:  Lasse Skovgaard; Inge Kryger Pedersen; Marja Verhoef
Journal:  BMC Complement Altern Med       Date:  2014-02-18       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.